Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Luminex Corp (LMNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Bio-Rad Labs-A is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (BIO , LMNX , ILMN , NEO , A )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

ILMN : 270.83 (-0.33%)
LMNX : 27.57 (-0.29%)
BIO : 289.06 (+0.05%)
Luminex (LMNX) Beats Q1 Estimates on ARIES Platform Strength

Luminex (LMNX) gains on ARIES and VERIGENE platforms in Q1; a solid guidance encourages.

CHE : 328.24 (+0.06%)
LMNX : 27.57 (-0.29%)
BAX : 72.41 (+0.08%)
ISRG : 457.79 (-0.20%)
Shares of Luminex Corp Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (LMNX , PRAH , QGEN , PKI , A )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

LMNX : 27.57 (-0.29%)
PRAH : 80.89 (-0.65%)
Luminex Corporation Reports First Quarter 2018 Financial Results

Luminex Corporation (Nasdaq:LMNX) today announced financial results for the first quarter of 2018. Financial and operating highlights for the quarter include:

LMNX : 27.57 (-0.29%)
Factors of Influence in 2018, Key Indicators and Opportunity within Bottomline Technologies, SkyWest, Pacific Biosciences of California, Argos Therapeutics, Luminex, and Fiserv -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bottomline Technologies, Inc....

SKYW : 57.25 (+2.97%)
EPAY : 47.35 (+0.74%)
ARGS : 0.1790 (+4.37%)
PACB : 2.58 (-1.90%)
FISV : 71.68 (-0.26%)
LMNX : 27.57 (-0.29%)
Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018

AUSTIN, Texas , April 16, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2018 on Monday, May...

LMNX : 27.57 (-0.29%)
Luminex (LMNX) Product Portfolio Solid, Competition Rife

Luminex's (LMNX) flagship VERIGENE and ARIES systems are likely to boost its growth trajectory.

ATHN : 153.45 (-0.10%)
LMNX : 27.57 (-0.29%)
BIO : 289.06 (+0.05%)
PKI : 75.62 (-0.53%)
Why Is Luminex (LMNX) Up 11.2% Since Its Last Earnings Report?

Luminex (LMNX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

LMNX : 27.57 (-0.29%)
Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Nanostring Techn (NSTG , LMNX , TMO , PRAH , ILMN )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

TMO : 215.97 (-0.25%)
LMNX : 27.57 (-0.29%)
NSTG : 12.50 (-1.50%)
Luminex Corporation to Present at the Barclays Global Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held March 13-15, 2018, in Miami.

LMNX : 27.57 (-0.29%)
Recent Analysis Shows Luminex, OFG, W.P. Carey, Allstate, Ashford Hospitality Prime, and S&P Global Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Luminex Corporation (NASDAQ:LMNX),...

OFG : 14.25 (-0.70%)
ALL : 95.52 (-0.07%)
LMNX : 27.57 (-0.29%)
AHP : 10.38 (+0.29%)
SPGI : 199.82 (-0.56%)
WPC : 65.52 (-0.36%)
Luminex (LMNX) Banks on Solid Product Line, Competition Rife

Luminex's (LMNX) extensive product line and rising revenues raise optimism. However, a challenging reimbursement scenario is likely to mar prospects.

HCA : 103.60 (+0.09%)
LMNX : 27.57 (-0.29%)
CNC : 116.61 (+0.12%)
HAE : 90.38 (-0.43%)
Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View

Luminex's (LMNX) favorable tidings at the regulatory front in Q4 buoy optimism.

PETS : 37.21 (+0.65%)
BDX : 225.60 (-0.29%)
LMNX : 27.57 (-0.29%)
PKI : 75.62 (-0.53%)
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2017. Financial and operating highlights for the quarter and full-year include:

LMNX : 27.57 (-0.29%)
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

AUSTIN, Texas , Feb. 12, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2017.  Financial and operating highlights...

LMNX : 27.57 (-0.29%)
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

AUSTIN, Texas , Feb. 6, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the LEERINK Partners 7 th Annual Global Healthcare Conference...

LMNX : 27.57 (-0.29%)
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the LEERINK Partners 7th Annual Global Healthcare Conference to be held February 14-15, 2018, in New York, NY.

LMNX : 27.57 (-0.29%)
ResMed (RMD) Rides on Product Launches, Robust Global Growth

ResMed's (RMD) product launches and strategies to gain traction in the sleep-disordered breathing market. This upside is further likely to drive the stock in the future.

PETS : 37.21 (+0.65%)
MYGN : 35.94 (+1.27%)
LMNX : 27.57 (-0.29%)
RMD : 103.13 (+0.40%)
Mckesson (MCK) to Report Q3 Earnings: A Beat in the Cards?

McKesson's (MCK) Specialty Health unit is likely to drive the company's top line in the third quarter of fiscal 2018.

COO : 229.59 (-1.00%)
MCK : 144.03 (-1.91%)
LMNX : 27.57 (-0.29%)
BIO : 289.06 (+0.05%)
What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?

Despite solid prospects in the emerging markets, Becton, Dickinson (BDX) is likely to witness sluggishness in BD Medical and BD Life Sciences in Q1.

COO : 229.59 (-1.00%)
BDX : 225.60 (-0.29%)
LMNX : 27.57 (-0.29%)
BIO : 289.06 (+0.05%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar